A Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction

Sponsor
Yonsei University (Other)
Overall Status
Unknown status
CT.gov ID
NCT02659852
Collaborator
(none)
70
1
2
48
1.5

Study Details

Study Description

Brief Summary

Malignant obstructive jaundice is a common complication of advanced stage cholangiocarcinoma, GB cancer, and pancreatic cancer. In biliary stricture by malignancy, biliary drainage with placement of self-expanding metal stent (SEMS) for palliation is the therapy of choice in these patients. On hilar biliary malignant obstruction, bilateral stent used to be inserted. There are two kinds of bilateral metal stent insertion methods in hilar biliary malignant obstruction. (Stent in stent vs. side by side) Previously, two studies was conducted to show the superiority of bilateral metal stent insertion between stent in stent and side by side. Biliary drainage and stent patency was a little superior in side by side than stent in stent. But, complication related with bilateral metal stent was increased in patients with side by side method. Another study showed that there was no significant difference between those bilateral stent insertion methods. The most important concern about side by side method is associated with portal vein thrombosis by bilateral stent diameter. Selection of proper stent insertion method in patients with hilar malignant biliary obstruction is still controversial.

The purpose of this study is to investigate the patency of stent and survival of patients in side by side method (6mm sized M type) compared to stent in stent method (10mm sized LCD type) in patient with hilar malignant biliary obstruction.

Condition or Disease Intervention/Treatment Phase
  • Procedure: side by side
  • Procedure: stent in stent
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Prospective Randomized Study for Efficacy of Side-by-side Compared to Stent-in-stent Technique in the Endoscopic Management of Malignant Hilar Biliary Obstruction
Study Start Date :
Jan 1, 2016
Anticipated Primary Completion Date :
Jan 1, 2020
Anticipated Study Completion Date :
Jan 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Side by side group

Procedure: side by side
Stenting generally begins with selective guidewire cannulation into the left and right intrahepatic bile ducts. Self-expandable metallic stent(SEMS) deployment is the conventional method and parallel SEMS can be inserted. SEMS deployment can be performed serially or simultaneously.

Active Comparator: Stent in stent group

Procedure: stent in stent
After first SEMS deployment, contralateral placement of a second SEMS through the mesh of the first deployed stent was done and it looks like a Y configuration.

Outcome Measures

Primary Outcome Measures

  1. Median patency duration [1 year after stent insertion]

    Median patency duration from stent insertion date to stent occlusion date or last follow up date if stent is patent

Secondary Outcome Measures

  1. Overall survival [1 year]

  2. complication rate [1 year]

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Pathologically confirmed hilar malignant biliary obstruction or clinically defined malignant biliary obstruction

  • older than 20 years old

Exclusion Criteria:
  • Operable case

  • Non-hilar biliary malignant obstruction

  • Duodenal obstruction

  • Other cancer except biliary malignancy

  • uncontrolled infection status

  • Eastern Cooperative Oncology Group ≥ 3

  • No signed informed consent

  • Failed endoscopic approach to duodenum or biliary tract

Contacts and Locations

Locations

Site City State Country Postal Code
1 Severance Hospital, Yonsei University Seoul Korea, Republic of 120-752

Sponsors and Collaborators

  • Yonsei University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Yonsei University
ClinicalTrials.gov Identifier:
NCT02659852
Other Study ID Numbers:
  • 4-2015-1072
First Posted:
Jan 20, 2016
Last Update Posted:
Jan 28, 2019
Last Verified:
Jan 1, 2019
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Yonsei University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 28, 2019